Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Aug 26;14(17):6028.
doi: 10.3390/jcm14176028.

Advances in Endoscopic Diagnosis and Management of Cholangiocarcinoma

Affiliations
Review

Advances in Endoscopic Diagnosis and Management of Cholangiocarcinoma

Usamah Chaudhary et al. J Clin Med. .

Abstract

Cholangiocarcinoma (CCA) is an aggressive malignancy originating from the epithelial lining of the intrahepatic or extrahepatic bile ducts. Although rare globally, its mortality closely mirrors incidence due to late-stage presentation of the disease and limited curative options. While surgical resection and liver transplantation remain the cornerstone treatments for those with resectable disease, endoscopic techniques have emerged as versatile tools for diagnosis, therapy, and palliation. In recent years, there have been major advancements in endoscopic therapies, including radiofrequency ablation (RFA), intraluminal brachytherapy (ILBT), and photodynamic therapy (PDT). The current narrative review serves to provide an overview of current and emerging endoscopic strategies for CCA, emphasizing diagnostic capabilities, therapeutic approaches, palliative interventions, and future directions.

Keywords: advanced endoscopy; biliary tract cancer; cholangiocarcinoma; photodynamic therapy; radiofrequency ablation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Banales J.M., Cardinale V., Carpino G., Marzioni M., Andersen J.B., Invernizzi P., Lind G.E., Folseraas T., Forbes S.J., Fouassier L., et al. Expert Consensus Document: Cholangiocarcinoma: Current Knowledge and Future Perspectives Consensus Statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) Nat. Rev. Gastroenterol. Hepatol. 2016;13:261–280. doi: 10.1038/nrgastro.2016.51. - DOI - PubMed
    1. Khan S.A., Tavolari S., Brandi G. Cholangiocarcinoma: Epidemiology and Risk Factors. Liver Int. 2019;39:19–31. doi: 10.1111/liv.14095. - DOI - PubMed
    1. Ilyas S.I., Gores G.J. Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma. Gastroenterology. 2013;145:1215–1229. doi: 10.1053/j.gastro.2013.10.013. - DOI - PMC - PubMed
    1. National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology. Biliary Tract Cancers. 2025. [(accessed on 19 August 2025)]. Available online: https://www.nccn.org/professionals/physician_gls/pdf/btc.pdf. - PubMed
    1. Mukkamalla S.K.R., Naseri H.M., Kim B.M., Katz S.C., Armenio V.A. Trends in Incidence and Factors Affecting Survival of Patients with Cholangiocarcinoma in the United States. J. Natl. Compr. Cancer Netw. 2018;16:370–376. doi: 10.6004/jnccn.2017.7056. - DOI - PubMed

LinkOut - more resources